{"nctId":"NCT00313846","briefTitle":"Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee","startDateStruct":{"date":"2003-04"},"conditions":["Osteoarthritis"],"count":529,"armGroups":[{"label":"BTDS","type":"EXPERIMENTAL","interventionNames":["Drug: Buprenorphine transdermal patch"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Buprenorphine transdermal patch","otherNames":["Butrans™"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* clinical diagnosis of chronic osteoarthritis of the hip or knee for 1 year or longer.\n* an average pain due to osteoarthritis of moderate, moderately-severe, or severe for the 14 days prior to enrollment.\n\nExclusion Criteria:\n\n* ingest opioid analgesics on a daily basis.\n* ingest \\>2500 milligrams (mg) acetaminophen on a daily basis.\n* require \\<20 mg or \\>80 mg of morphine (or opioid equivalents) per day for control of their osteoarthritis pain.\n\nOther protocol-specific exclusion/inclusion criteria may apply.","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Time (Days) From First Administration of Double-blind Treatment to the Development of Inadequate Analgesia at the Primary Osteoarthritis Pain Site.","description":"Inadequate analgesia:\n\n* \"average pain over the last 24 hours\" score for pain at primary osteoarthritis (OA) site ≥ 5 on any 2 days of any 7-day dosing period, on a scale from 0 - 10 (0 = no pain to 10 = pain as bad as you can imagine)or;\n* \\>1000 mg/day acetaminophen for pain at primary OA site for ≥ 2 days in any 7-day dosing period, or;\n* ingested nonstudy opioid analgesic medication for pain at primary OA site. Score: lowest score = shortest time to inadequate analgesia; highest score = longest time to inadequate analgesia.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.3","spread":"0.77"},{"groupId":"OG001","value":"17.2","spread":"0.89"}]}]}]},{"type":"SECONDARY","title":"Daily Maximum \"Pain Right Now\" Score for the Primary Osteoarthritis (OA) Pain Site","description":"The daily maximum 'pain right now' score for the primary OA pain site was calculated over the last 7-day dosing period in the double-blind phase or the last 7-day dosing period prior to emergence of inadequate analgesia or discontinuation from the double-blind phase. Collected prior to ingestion of acetaminophen. \"Pain right now\" scale score for primary OA site on a scale from 0-10 (where 0= no pain and 10= worst pain you can imagine).","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":"0.15"},{"groupId":"OG001","value":"3.2","spread":"0.14"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":162},"commonTop":["Nausea","Headache","Dizziness","Constipation","Somnolence"]}}}